OPC Pharmaceutical JSC (HOSE: OPC)

Market Cap	1.51T
Revenue (ttm)	982.73B
Net Income (ttm)	94.20B
Shares Out	64.05M
EPS (ttm)	1,470.00
PE Ratio	16.05
Forward PE	n/a
Dividend	1,500.00 (6.44%)
Ex-Dividend Date	May 13, 2024

Volume	100
Open	23,600
Previous Close	23,300
Day's Range	23,600 - 23,600
52-Week Range	21,550 - 27,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About OPC Pharmaceutical JSC

OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally. Its primary products include cardiovascular, nerve, nutrition, vitamins and minerals, respiratory system, urinary, musculoskeletal system, external use, digestion, endocrine, pain relief-inflammation, and others. The company also produces and trades in pharmaceutical products, materials, machinery, medical equipment, chemicals, cosmetics, functional ...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 926
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: OPC

Financial Performance

In 2023, OPC Pharmaceutical JSC's revenue was 1.00 trillion, a decrease of -14.23% compared to the previous year's 1.17 trillion. Earnings were 104.69 billion, a decrease of -18.29%.